Draxxin 25 (Tulathromycin) Injectable Solution for Cattle and Swine, 25mg/mL

Supplied By: Zoetis (10022116)


SKU
082754


Unit of
Measure
100mL


Pack
Type
Vial


Case
Qty
24

{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Jul- 2024 Jun- 2024 May- 2024 Apr- 2024 Mar- 2024 Feb- 2024 Jan- 2024 Dec- 2023 Nov- 2023 Oct- 2023 Sep- 2023 Aug- 2023 Jul- 2023
{{purchaseHistoryItem}}


SKU
082754


Size
100mL

Case
Qty
24

Purchase History

Jul- 2024 {{productPurchaseHistory['082754'][0]}} Dec- 2023 {{productPurchaseHistory['082754'][0+7]}}
Jun- 2024 {{productPurchaseHistory['082754'][1]}} Nov- 2023 {{productPurchaseHistory['082754'][1+7]}}
May- 2024 {{productPurchaseHistory['082754'][2]}} Oct- 2023 {{productPurchaseHistory['082754'][2+7]}}
Apr- 2024 {{productPurchaseHistory['082754'][3]}} Sep- 2023 {{productPurchaseHistory['082754'][3+7]}}
Mar- 2024 {{productPurchaseHistory['082754'][4]}} Aug- 2023 {{productPurchaseHistory['082754'][4+7]}}
Feb- 2024 {{productPurchaseHistory['082754'][5]}} Jul- 2023 {{productPurchaseHistory['082754'][5+7]}}
Jan- 2024 {{productPurchaseHistory['082754'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

DRAXXIN® Injectable Solution is indicated for the treatment and control of respiratory disease in beef and nonlactating dairy cattle at high risk of developing bovine respiratory disease (BRD) associated with Mannheimia (pasteurella) haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis.

DRAXXIN Injectable Solution is also indicated for the treatment of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica, Haemophilus parasuis, and Mycoplasma hyopneumoniae; and for the control of SRD associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, and Mycoplasma hyopneumoniae in groups of pigs where SRD has been diagnosed.

Features & Benefits

  • Provides up to 14 days of therapy in single dose
  • Effective control and treatment of 4 major bacterial pathogens associated with BRD
  • A single-dose treatment protocol can improve antimicrobial treatment compliance
  • Offers convenience of a short 18-day meat withdrawal